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Abstract: Based on the results of a Horizon Scanning exercise sponsored by the Society of Environmental Toxicology and
Chemistry that focused on advancing the adverse outcome pathway (AOP) framework, the development of guidance related to
AOPnetwork developmentwas identified as a critical need. This not only includedquestions focusingdirectly onAOPnetworks,
but also on related topics such as mixture toxicity assessment and the implementation of feedback loops within the AOP
framework. A set of two articles has been developed to begin exploring these concepts. In the present article (part I), we
consider the derivation of AOP networks in the context of how it differs from the development of individual AOPs. We then
propose the use of filters and layers to tailor AOP networks to suit the needs of a given research question or application. We
briefly introduce a number of analytical approaches that may be used to characterize the structure of AOP networks. These
analytical concepts are further described in a dedicated, complementary article (part II). Finally, we present a number of case
studies that illustrate concepts underlying the development, analysis, and application of AOP networks. The concepts
described in the present article and in its companion article (which focuses on AOP network analytics) are intended to serve as a
starting point for further development of the AOP network concept, and also to catalyze AOP network development and
application by the different stakeholder communities. Environ Toxicol Chem 2018;37:1723–1733. C 2018 The Authors.
Environmental Toxicology and Chemistry published by Wiley Periodicals, Inc. on behalf of SETAC.
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Adverse outcome pathways (AOPs) constitute an important
framework that can help support greater and more effective use
of mechanistic, or pathway-based, data in risk assessment andarticle includes online-only Supplemental Data.
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yonlinelibrary.com/ETCregulatory decision-making. While the conceptual underpin-
nings of AOP frameworks date back to at least the late 1980s
(LaLone et al. 2017a); AOPs have rapidly evolved from a
conceptual paradigm (Ankley et al. 2010) into a formalized
framework for organizing biological and toxicological knowl-
edge according to a set of principles and guidelines that are
generally accepted by the scientific and regulatory communities
(Organisation for Economic Co-operation and Development
2013a, 2015; Villeneuve et al. 2014b), and for disseminating that
knowledge through an internationally harmonized knowledge-
base (Society for the Advancement of Adverse Outcome
Pathways 2017; Organisation for Economic Co-operation andC 2018 The Authors
1724 Environmental Toxicology and Chemistry, 2018;37:1723–1733—D. Knapen et al.Development 2017). Nonetheless, further development of the
framework and the tools, approaches, and concepts surround-
ing its application is required to fully realize its potential and
acceptance by society.
In response to the recognized need to continue advancing
the framework, the Society of Environmental Toxicology and
Chemistry (SETAC) sponsored a global Horizon Scanning
exercise to identify major outstanding topics and challenges
related to the AOP framework and its application (LaLone et al.
2017a). Based on a survey of the international stakeholder
community, 4 major topics/themes that needed further devel-
opment were identified: 1) enhancement of communication,
outreach, and stakeholder engagement in the development and
application of AOP knowledge; 2) enhancement of regulatory
use and acceptance of the AOP framework and facilitation of its
incorporation into regulatory practices; 3) enhanced use of the
framework for quantitative assessments and applications; and
4) development of approaches for deriving, interrogating, and
applying networks of AOPs, which is the topic of the present
article.
As outlined by Villeneuve et al. (2014b), individual AOPs are
viewed as a pragmatic unit of development and evaluation. It is
tractable for an individual or a research team to describe and
establish, through both biological plausibility and supporting
evidence, how a defined perturbation of a biological system can
lead, in a causal manner, to a particular adverse outcome. It is far
less tractable for that individual or team to describe all the
possible adverse effects a given perturbation may cause, or,
conversely, all the different perturbations through which
stressors may evoke a particular adverse outcome (e.g.,
reductions in survival, growth, and reproduction; increased
risk of disease). It is even more daunting to consider describing
those possibilities for all the different taxa, life stages, and sexes
(where relevant) that are of interest to a stakeholder. However, at
the same time it was recognized that the “one perturbation–one
adverse outcome” model that an individual AOP represents is a
gross oversimplification of both the complexity of biological
systems and the consequences of exposures to the stressors that
they face. Inmost real-world scenarios, exposures are tomultiple
stressors (i.e., mixtures), not just one stressor at a time. Likewise,
even single stressors may induce toxicity by more than one
mechanism, via interaction of the chemical with multiple targets
in an organism or via interaction with a single target found in
multiple compartments (e.g., cell types, tissues, organs, etc.)
within a complex organism. Thus, most often, AOPs cannot be
considered in isolation. One needs to think about potential
interactions among pathways and consider how those inter-
actions may alter the trajectory or intensity of the effects
resulting from a chemical exposure.
Recognizing this, one of the core principles of AOP
development was that, in contrast to individual AOPs as
pragmatic units of development, AOP networks are viewed as
the most likely units of prediction (Villeneuve et al. 2014b). In
turn, the formalization of the AOP framework, and its
implementation via a knowledgebase structure that allowed
for sharing of an AOP’s modular units (key events and key
event relationships, as found in AOP-Wiki; Society for theC 2018 The AuthorsAdvancement of Adverse Outcome Pathways 2017), was
conceived and designed to allow for de facto construction
of more complex and comprehensive networks from individual
AOPs. In this way, a more accurate representation of biological
and toxicological complexity that covers more and more of
the susceptible taxonomic space and biological contexts (e.g.,
life stage, sex, impacts in or on different target organs) can be
built up gradually through the independent contributions of
individuals or groups.
A vision for AOP networks has just begun to be realized.
Following publication of principles and best practices for
AOP development (Villeneuve et al. 2014b, 2014c) and public
release of the AOP-Wiki (Society for the Advancement of
Adverse Outcome Pathways 2017) in 2014, time was needed
to allow for an accumulation of a sufficient number of AOPs in
the AOP knowledgebase to actually begin exploring their
connectivity. Likewise, technical and practical challenges in
the development of sharable, modular key event and key
event relationship units in the public AOP knowledgebase
(e.g., the development of naming conventions, search tools,
guidance and training materials, etc.) initially hampered rapid
assembly of these de facto networks. Nonetheless, over the
last 3 yr, a critical mass of AOP descriptions has started to
accumulate, and some of the challenges have been over-
come. This has led to the recent realization of some of the first
examples of AOP networks (Knapen et al. 2015; Angrish et al.
2016, 2017; Margiotta-Casaluci et al. 2016; LaLone et al.
2017b), as well as opportunities to address key concepts
related to the development, analysis, and application of AOP
networks.
The present set of 2 articles begins to explore these concepts.
In the present article (part I), derivation of AOP networks is
considered in the context of how it differs from development of
individual AOP descriptions. We then discuss the application of
filters and layers to refine and enrich derived AOP networks so
that they may be tailored to address specific questions of
interest. Modifications to the AOP knowledgebase that may be
needed accordingly are also considered. We then briefly
introduce a number of analytical and computational approaches
that may be used to characterize and analyze the structure of
AOP networks to derive information that can guide research and
regulatory decision-making. These analytical concepts are
further developed and described in part II by Villeneuve et al.
(2018), including the use of techniques derived from graph
theory (Trudeau 2013) and network science (Lewis 2009), to
analyze network topology, the identification of critical paths, and
the characterization of interactions among AOPs in a network.
Finally, we present a number of application case studies that
illustrate concepts underlying the development and analysis of
AOP networks, and how those concepts tie in with ultimate
application. Although the article is not comprehensive in scope,
the intent is to provide an enhanced understanding of AOP
network development, AOP network analysis (Villeneuve et al.
2018, part II), and applications of AOPs; as well as to provide
perspectives on how some of the challenges identified through
the Horizon Scanning exercise (LaLone et al. 2017a) can be
addressed.wileyonlinelibrary.com/ETC
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A first and relevant question is: What exactly is an AOP
network? AnAOPnetwork is defined as an assembly of 2 ormore
AOPs that share one or more key events, including specialized
key events such as molecular initiating events and adverse
outcomes (Table 1). Different AOPs diverging from a single
molecular initiating event, or converging to a single adverse
outcome, therefore also form AOP networks even if they do not
have any other key event in common. Development of individual
AOPs can be thought of as the process of 1) graphically defining
a sequence of key events that link a molecular initiating event to
a defined adverse outcome, 2) describing the change in state
that each key event represents and how it is measured, and 3)
detailing the weight of evidence that supports inference or
extrapolation from one key event to the next in the sequence
based on biological plausibility, empirical support, and quanti-
tative understanding (Villeneuve et al. 2014b). The AOP
networks can be thought of as emerging from the description
of individual AOPs, as soon as key events are described that are
shared between 2 or more AOPs. Either the description of
networked key events can be an intentional process that is part
of the strategy of an AOP developer, or the fact that certain key
events are shared among AOPs can be discovered after AOPs
have been developed independently. When one is considering
different AOP network development processes, it is therefore
useful to distinguish between network-guided AOP develop-
ment and AOP network derivation. Whereas AOP network
derivation is defined as a formal AOP network development
process based on extracting and linking information that is
available in the AOP-Wiki, network-guided AOP development isTABLE 1: Coming to terms with AOP networks
Term
AOP network An assembly of 2 or more AOPs that sh
AOP network development Broad term referring to the description o
Network-guided AOP
development
AOP network development strategy inv
more intentionally shared key events
AOP network derivation AOP network development by manuall
from the AOP-Wiki.
AOP network analytics Broad term referring to the analysis of
properties, such as topological featur
AOP network filter AOP network development tool to refin
network are included in downstream
AOP network layer Graphical AOP network visualization too
loops to facilitate interpretation witho
AOP network topology The overall shape and structure of an A
network (i.e., key events and key eve
Convergent topology Topology in which key events from 2 o
outcome, representing a range of po
Divergent topology Topology in which 2 or more key event
event, representing a range of possib
Mixed topology Topology showing local divergent and c
motifs such as bow-tie motifs, which
Critical path The path through an AOP network cons
standpoint. A critical path does not n
knowledgebase.
Interaction between AOPs One AOP affecting another AOP in suc
outcome that would be observed had
AOP¼ adverse outcome pathway.
wileyonlinelibrary.com/ETCintroduced as a rather broadly defined concept that includes
many different AOP network development approaches that do
not necessarily rely on database extraction procedures.
Network-guided AOP development
When AOPs are developed in the AOP-Wiki, an AOP network
is created by default whenever a key event or key event
relationship description is linked to more than one AOP. This is
important because it implies that AOP developers are not
restricted to describing only linear paths, and can thus
intentionally conceive and describe structures that are more
complex than the typical one perturbation–one outcome unit.
This process could be thought of as network-guided AOP
development. The advantage of network-guided AOP develop-
ment is that it is not conceptually andmethodologically different
from the development and description of individual AOPs: the
same principles, guidance, and practices in terms of description
within the AOP-Wiki apply, and no additional tools are required.
To develop an AOP network, there is no need to do anything
differently than one would for describing a linear AOP, other
than to intentionally share key event or key event relationship
descriptions (pages) among more than one AOP, a functionality
that is currently built into the AOP-Wiki.
Currently, many AOPs are being developed in this network-
guided fashion (see Angrish et al. 2016; Nelson et al. 2016;
Stinckens et al. 2016; Cavallin et al. 2017; LaLone et al. 2017b).
However, it is expected that as the AOP knowledgebase
matures, AOP development will increasingly focus on filling
data and knowledge gaps in the AOP-Wiki. The AOP networkCharacteristics
are 1 or more key events.
r development of AOP networks, irrespective of the strategy employed.
olving the development of at least 2 individual AOPs containing 1 or
.
y or programmatically extracting AOPs relevant for a given application
AOP networks to reveal, identify, or investigate specific network
es, critical paths, or interactions between AOPs.
e which key events and key event relationships from a given AOP
applications and analysis based on specified filter criteria.
l to overlay a given AOP network with additional data such as feedback
ut overly complicating the underlying framework.
OP network, describing the way in which the constituent parts of the
nt relationships) are interrelated or arranged.
r more AOPs are directed toward a common key event or adverse
ssible upstream causes.
relationships branch off from a single molecular initiating event or key
le downstream outcomes.
onvergent regions within the overall network, possibly featuring specific
could represent important points of biological integration.
idered most significant from an investigational, biological, or regulatory
ecessarily correspond to a single AOP described in the AOP
h a way that it modulates the adverse outcome compared with the
the interaction not taken place.
C 2018 The Authors
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exercise in assembling data that already exist in the AOP
knowledgebase. The process of developing AOP networks by
extracting existing data from the AOP-Wiki and assembling a
network based on those AOPs rather than on de novo
descriptions of linked AOPs is called AOP network derivation.AOP network derivation
The first step in network derivation is to extract all AOPs that
are relevant for a given application from the AOP-Wiki (Figure 1).
The criteria that define which AOPs are relevant will vary and will
be defined by the application or stakeholder needs. Theoreti-
cally, the AOP knowledgebase can be queried for any property
of an AOP, key event, or key event relationship that has been
appropriately described and/or structurally annotated. Some
examples of extraction criteria include the following: AOPs
leading to a single adverse outcome of interest, AOPs known to
be induced by a particular stressor or group of stressors, AOPs
having key events that map to a particular data set (e.g., a
collection of positive high-throughput screening assay re-
sponses observed for a particular chemical or mixture of
chemicals), AOPs that have a particular species in their
applicability domain, AOPs that have key events for a particular
tissue type, and so on.
Extraction can be achieved manually, for example by
inspecting dedicated pages in the AOP knowledgebase that
list all the AOPs that a particular key event links to. However,
manual extraction of AOP networks could rapidly become
tedious as well as impractical as the AOP knowledgebase grows.
Thus, it is important to develop computational tools designed
for this purpose, such as the AOPXplorer (http://apps.
cytoscape.org/apps/aopxplorer). Using AOPXplorer, any struc-
tured annotation field in the AOP knowledgebase can be
queried computationally to derive an AOP network. Once such
an automated extraction process is complete, the resulting
collection of AOPs can be assembled based on their topologies
of shared key events and key event relationships into an AOPFIGURE 1: Graphical representation of the adverse outcome pathway (A
network is constructed by querying the AOP knowledgebase (AOP-KB). Filter
for a given application or research question. Layers can be added in a next ste
analyzed to produce metrics related to the topology and other properties o
C 2018 The Authorsnetwork that is then called a primary AOP network (Figure 1). In
some cases, the resulting primary network will be directly
suitable for a certain application. In others, it may be desirable to
refine (simplify and/or enrich) the network using a series of filters
and data layer options, or to more deeply interrogate and
statistically analyze the network, as discussed in the next section.Refining AOP networks using filters
The structural complexity of AOP networks will depend on
various factors. Ideally, AOP network derivation tools should
include ways to focus and refine the network to fit the needs of a
given application and enhance the information content con-
veyed from the overall network diagram. For example, risk
assessment of individual chemicals ormixturesmight be focused
on a particular effect (e.g., impaired reproduction) in a specific
class of organisms. In such a scenario, onemight want to remove
AOPs that relate to nonreproductive endpoints, as well as AOPs
that are relevant to other taxa. On the other hand, efforts
targeting mode of action identification could benefit from
examination of highly branched networks encompassing many
different MIEs and their associated pathways. Thus, it was
conceived that one should be able not only to construct a
primary network based on extraction criteria, but also to filter
that network based on additional annotation terms that would
allow one to focus on the pathway(s) of greatest interest.
It is envisioned that AOP network filters can be used to further
define which key events and key event relationships from the
primary AOP network would be included in downstream
applications and analysis (Figure 1). For example, the structured
key event and key event relationship domain of applicability
terms selected in the AOP knowledgebase could be used to
restrict a network to only those key events and key event
relationships that are relevant to a given life stage, thereby
simplifying the overall network. Alternatively, one might want to
filter an AOP network to only those key events measured at a
defined biological level of organization; to select appropriate
endpoints, one might measure in a specific cell line or tissue. AOP) network derivation–refinement–analysis workflow. A primary AOP
s are then applied to derive a filtered network containingAOPs of interest
p to add data relevant to the application. Finally, the AOP network can be
f the network.
wileyonlinelibrary.com/ETC
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terms that are part of the AOP descriptions (e.g., taxonomic
applicability) or on network metrics (e.g., how strongly
connected key events are to the network) could be envisioned.
Supplemental Data Table S1, provides a list of possible filters
that could be envisioned, including filters for taxonomic, life
stage, or sex applicability, network metrics, and critical paths.
Each could be used to help tailor an AOP network to a given
problem formulation or research question. Finally, we propose a
confidence assessment filter that can be used to filter AOP
networks based on various weight-of-evidence, biological
plausibility, essentiality, and other assessments of the constitu-
ent AOPs.Visualizing AOP network data using layers
A simplified representation of a set of key events and key
event relationships (i.e., anAOPnetwork) can easily be visualized
graphically, where each unique key event is represented by a
single node, and the key event relationships are represented by
edges (Figure 1). Although such a simple graphical representa-
tion can depict the general structure of an AOP network, it is not
a practical means of displaying and interrogating all the complex
information captured within each of its key event and key event
relationship descriptions. In addition, one may wish to supple-
ment a network with additional data that are external to the AOP
knowledgebase (e.g., experimental data), which can further
convolute the information associated with an AOP network. To
aid in the visualization and interpretation of the complex
information in AOP networks, we propose a mechanism to
visually superimpose this information, as needed, as layers on
top of an AOP network image (Figure 1). These AOP network
layers can be viewed as analogous to the data layers employed
in geographic information systems: information relevant to
interpretation or application of an AOP network can be laid over
the filtered AOP network, much like traffic or public transporta-
tion information is laid over a city map. Ideally these layers could
capture data derived from structured annotation fields within the
AOP-Wiki, and they could also incorporate other types of data
that are not necessarily part of formal AOP descriptions.
There has been resistance to the explicit representation of
additional data such as feedback loops as additional types of
nodes and edges in an AOP network, because they may overly
complicate network interpretation for many applications. On
the other hand, for some applications, such additional levels of
detail may yield insights that may allow for more accurately
predicting biologically relevant outcomes. Layers add infor-
mation to an AOP network without modifying or influencing
the network’s overall properties, structure, and topology, and
they are viewed as a way to address competing desires for
greater information richness and detail on the one hand versus
clear-cut interpretive simplicity on the other hand. The
consideration of feedback loops and modulating factors within
AOPs and AOP networks provides a useful example of this. At
present, events associated with a feedback loop may be
included as key events in the AOP when a feedback response is
causally linked to the adverse outcome and is measurable. Inwileyonlinelibrary.com/ETCother cases, however—for example, when an understanding of
the feedback loop may aid in predicting how severely a
particular key event must be perturbed to progress further
along the pathway—knowledge of the feedback loop can be
included in the “quantitative understanding of the linkage”
section of the relevant key event relationship pages (see Q&A
13 in LaLone et al. 2017a). Therefore, feedback, feedforward,
or other types of signaling motifs or loops are not specifically
annotated as such in AOP descriptions and are thus very
difficult to identify automatically. Likewise, modulating factors
that are extrinsic to the AOP network (i.e., are not driven by
interactions among existing key events found in the network),
such as dietary factors, genetic susceptibility or resistance,
disease states, environmental factors, and so on, are currently
only captured in the free-text descriptions of quantitative
understanding of the key event relationships. Whereas
potential intrinsic modulating factors are captured de facto
in the structure of the network because they arise from a
shared key event or key event relationship and, therefore, do
not need explicit annotation, extrinsic modulating factors
require separate descriptions and anchoring to the AOP
network.
Operationally (i.e., from the perspective of further develop-
ment of theAOP knowledgebase), the implementation of certain
types of layers would involve the introduction of additional
structured annotation fields (Ives et al. 2017) in the key event and
key event relationship descriptions of the AOP knowledgebase.
In the case of knownmodulating factors, this could, for example,
involve the introduction of an optional “modulating factor” field
to key event relationship descriptions, whereby users could
define a modulating factor and provide additional text descrip-
tion and supporting references. An advanced implementation of
feedback loop layers could allow future key events also affecting
the feedback loop to reveal interactions between AOPs that are
not necessarily evident from individual key events. However,
even at the most basic level, the ability to apply a layer that
identifies those key event relationships for which feedback or
modulating factors are known to influence response–response
relationships could be very informative and could signal a user to
explore the additional details provided in theAOPdescription to
determine whether they are relevant to the application in
question. Although these capabilities have not yet been
implemented as computational features of the AOP knowl-
edgebase, the concepts and features outlined in the present
article have been communicated to the AOP knowledgebase
development team to inform ongoing software development
aimed at enhancing the utility of AOP networks.
In addition to feedback loop layers and modulating factor
layers, a number of other data layers were identified that could
reflect taxonomic, life stage, and sex applicability domains,
genetic heterogeneity, tissue specificity, and temporality, as well
as quantitative response data (Supplemental Data, Table S2).
We propose that in combination, the use of filters and layers will
help to achieve a network representation that is suited for the
intended application and will make the AOP knowledgebase
more user friendly and useful for other intended audiences (such
as risk assessors) in addition to research scientists. Importantly,C 2018 The Authors
1728 Environmental Toxicology and Chemistry, 2018;37:1723–1733—D. Knapen et al.by overlaying certain data types on the key event relationships
within an AOP network, the network representation can be
transformed into a mathematical construct allowing for different
types of analyses to be applied (Figure 1; Villeneuve et al. 2018,
part II).Analyzing AOP networks
An AOP network organizes sets of biological perturbations
that may interact and influence one another in such a way that a
significant understanding of the biologymay be derived through
examination and analysis of the structure of the network.
Although visual examination of the network graph is compelling,
the use of techniques from graph theory (Trudeau 2013) and
network science (Lewis 2009) facilitates an encompassing review
of the network, especially when networks become larger and
more complex. Villeneuve et al. (2018, part II) address several
aspects of AOP network analytics, building on the basic AOP
network concepts described in the present article. They
specifically focus on 3 key elements: 1) AOP network topology
analysis, 2) critical path identification, and 3) characterization of
interactions among AOPs in a network. In the present article we
provide a few topical examples of analytical procedures thatmay
be applied to AOP networks to give the reader a brief
introduction to some of the concepts involved. The companion
article (Villeneuve et al. 2018, part II) gives a complete overview
and in-depth discussion of AOP analytics.FIGURE 2: Examples of adverse outcome pathway (AOP) network
analysis concepts and approaches. (A) Network topology analysis can
reveal converging, diverging, or mixed patterns. A mixed pattern can
take the shape of a bow-tie motif. (B) Two different examples of network
metrics calculated for the same hypothetical AOP network. The degree
of a node (key event [KE]) in the network is equal to the number of edges
(key event relationships [KERs]) connecting the node to the network and
is one way of expressing how connected that node is to the network. The
path occurrence is the number of times a node (KE) occurs in a path
connecting amolecular initiation event (MIE) to an adverse outcome (AO)
after evaluating all possible paths between the MIEs and AOs of the
network. The path occurrence may be an indication of the relative
importance of a node within the overall network.
C 2018 The AuthorsIn AOP network topology analysis, a large variety of metrics
can be calculated that describe the overall shape and structure
of the network or identify specific nodes in the network that may
be of particular interest. For example, one of the first topological
properties of interest is comprised of points of convergence and
divergence within a given network (Figure 2A). In a convergent
topology, AOPs are directed toward a common key event or
adverse outcome, whereas a divergent topology involves AOPs
branching off from a common molecular intiating event or key
event. Conceptually, the degree of convergence or divergence
of a network may affect the intensity of the adverse outcomes,
and analysis of convergence/divergence of AOP networks may
inform on the existence of potential additive, synergistic, or
antagonistic effects and interactions, or may, for example, be
used to develop assays that would capture a broad range of
molecular intiating events, versus assays predictive of a group of
related adverse outcomes, versus assays predictive of only a very
specific adverse outcome. Most real-life AOP networks will likely
be mixed networks (i.e., have local divergent and convergent
regions within the overall network). This could lead to specific
motifs, such as a node that is a local site of convergence and
divergence simultaneously, a mixed structure that would create
a bow-tie motif (Figure 2A) and could represent important
integrative biological signals. Computationally, a large number
of metrics can be calculated to describe network topologies,
each providing a specific view of the network and complemen-
tary opportunities for identifying network nodes of interest. A
few examples of such metrics are given in Figure 2B.
A second and highly relevant characteristic of AOP networks
is that they provide a framework for the description of the overall
landscape of potential adverse outcomes resulting from
particular biological perturbations. This can enable strategic
identification of paths that have the greatest biological
likelihood and/or relevance for risk assessment. Within an
AOP network, the most significant path from an investigational
or biological standpoint is termed the critical path. In the present
article we distinguish “path” from “pathway” to recognize that
the critical path may not necessarily follow an entire AOP, and
may in fact emerge only through the assembly and consideration
of the interactions betweenmultiple AOPs. The interpretation of
what constitutes a critical path can vary widely depending on the
context and perspective of the AOP developed or end user.
Critical paths may be representative of a specific research
question, or of the strongest weight of evidence for certain
elements of the network. They may also represent the most
toxicologically relevant path that may have great importance in
the application of AOP networks for risk assessment. This can in
turn aid identification of endpoints or assays that can serve as
useful alternatives to the direct measurement of apical adverse
outcomes (Organisation for Economic Co-operation and Devel-
opment 2016a). Also, AOP network–based critical path delinea-
tion efforts may be useful for identifying data gaps that are
required to achieve a complete critical path description in
scenarios in which the AOP network includes poorly supported
AOPs. Even though critical paths currently remain a relatively
loosely defined concept and quantitative approaches (i.e.,
quantitative AOP development) may be required to formulatewileyonlinelibrary.com/ETC
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recognize the need for different critical path identification
strategies, and distinguish among problem formulation, weight
of evidence, and biologically–toxicologically defined critical
paths, as well as the pure empirical identification of critical paths.
A third, and probably the most challenging, aspect of AOP
network analysis is the identification and characterization of
potential interactions between AOPs. The AOP interactions
describe how one or more components of a pathway may affect
another pathway in such a way that it modulates the adverse
outcome in terms of its biological properties, intensity,
probability, rate, and so on, compared with the outcome that
would be observed had the interaction not taken place.
Interactions between AOPs may be described as cross-talk
between AOPs, but because the concept of cross-talk is typically
associated with specific and rather strictly defined molecular
processes such as signal transduction cascades, “interactions” is
preferred as the descriptor. From a procedural perspective,
because nodes in AOPs represent directional changes in the
state of biological components (e.g., increased vs decreased
testosterone concentrations are 2 different key events) rather
than the biological components themselves (e.g., testosterone),
it is recognized that tools to automatically map key events
occurring on the same components during AOP network
extraction and analysis will be required before the full potential
of interaction analysis is achieved. Nevertheless, interactions are
anticipated to result in additive, synergistic, or antagonistic
responses (Vert and Chory 2011), and their analysis may provide
the opportunity to guide a more rational assessment of mixture
toxicity, for example (Villeneuve et al. 2018, part II).AOP NETWORK APPLICATION: CASE
STUDIES
As described by Villeneuve et al. (2014b), AOP networks
(compared with single AOPs) were envisioned to be a more
realistic representation of the complex biological interactions
that would, for example, occur in response to exposures to
chemical mixtures or single toxicants exhibiting multiple
biological activities. The development and analysis of AOP
networks have the potential to provide important information
regarding the interactions among multiple AOPs, and repre-
sent an interface between the specific toxic outcome captured
in a single AOP and modulation of those outcomes due to
interactions occurring in a systems biology context. In
addition, analysis of the intersections (shared key events and
key event relationships) among AOPs that make up an AOP
network can reveal unexpected or underappreciated biologi-
cal connections. Consequently, it is anticipated that AOP
networks will ultimately be more informative than individual
AOPs in a decision-making context. For example, when one is
mapping the landscape of AOPs for a particular adverse effect,
the network will indicate the points of convergence of different
pathways, which may indicate the most promising key event for
development of in vitro assays that can be tailored to capture
all the pathways upstream from that key event. This approach
may be very useful for informing the construction of integratedwileyonlinelibrary.com/ETCapproaches to testing and assessment to cover the relevant
biology for a wide range of potential adverse outcomes
(Tollefsen et al. 2014). The AOP networks may also offer
insights into approaches for evaluating the toxicity of mixtures
to understand how a chemical acting via one AOP may be
impacted by another chemical acting via another AOP in a
relevant mixture.
Although some of the most prominent potential applications
of AOP networks have been noted, other applications may
undoubtedly emerge. For example, AOP networks could help
speed the design of new drugs or chemicals by providing early
warnings of potential side effects or toxicological events that
could possibly end up in adverse effects. Likewise, mapping
layers of information on modulating factors onto an AOP
network could help to identify vulnerable subcategories of
people or wildlife whose susceptibility may be increased or
decreased as a function of health status, microelement
deficiencies, environmental stresses, and so on. These could
either exacerbate the adverse effect of a chemical, or (equally
undesirable) undermine or counteract the effect of a drug. Given
thebroad range of applications, it is impractical to illustrate them
all. Thus, in the context of the present article, we highlight just a
few application case studies that illustrate some of the concepts
of AOP network development and analysis described previously
and also show how those processes can be applied to help
address questions related to chemical safety assessment.Case study 1: AOP network for metabolic
disorders mediated by hepatic steatosis
The need to develop AOP networks to effectively evaluate
complex diseases was recently highlighted in the development
of mechanistic toxicity tests based on an AOP network for
hepatic steatosis, leveraging a large amount of publicly available
mechanistic, phenotypic, and toxicological liver data (Angrish
et al. 2016, 2017; Bell et al. 2016; Oki et al. 2016). Steatosis, also
known as fatty liver disease, is a regulatory endpoint and
pathologic condition in which energy metabolism is disrupted
and fat accumulates in the liver. Energy homeostasis is
dependent on the balance between energy intake and
expenditure, a process regulated by endocrine and cellular
communication among the brain, gut, and metabolic tissues
such as adipose, striated (skeletal and cardiac) muscle, pancreas,
and liver. At the molecular level, metabolism is coordinated by
broad chemical signals, including nutrients, hormones, and
environmental chemical signals that control systemic energy
homeostasis by binding to cognate cell surface, cytosolic, and
nuclear receptors. Chemical contact at any point along this
neuro–endocrine–organ network can impact complex signal
transduction, gene expression, protein activation cascades, and
so on to coordinate the energy demands of a biological system.
The challenge is that, because these receptors and signaling
pathways cross-talk, it is difficult to adapt existing assay data
(e.g., data from current ToxCastTM and Tox21 assays) to
strategies predictive of a steatotic outcome, possibly because
the events these assays represent are too far upstream of the
adverse outcome to allow for facilitation of reliable prediction ofC 2018 The Authors
FIGURE 3: Adverse outcome pathway (AOP) network for metabolic
disorders mediated by hepatic steatosis. The high level of cross-talk
between the different receptors and associated signaling pathways
complicates the use of existing high-throughput screening data as
predictors of a steatotic outcome. This challenge was overcome by
identifying a network topology converging into 4 key events (i.e.,
lipogenesis, and fatty acid uptake, efflux, and oxidation) that were
viewed as critical paths leading to steatosis. Assays measuring these
points of convergence integrate the complex interplay of upstream
events and translate them intomeasures that aremore directly related to
the adverse outcome. FA¼ fatty acid; TAG¼ triacylglycerol;
PI3K¼phosphatidylinositol-3-kinase; AKT¼protein kinase B;
PPAR¼peroxisome proliferator-activated receptor; LXR¼ liver X
receptor; CAR¼ constitutive androstane receptor; PXR¼pregnane X
receptor; FXR¼ farnesoid X receptor; RXR¼ retinoid X receptor.
1730 Environmental Toxicology and Chemistry, 2018;37:1723–1733—D. Knapen et al.outcomes. Effectively, the interactions that occur in between are
too complex to model practically or reliably.
In the steatosis AOPnetwork, this challengewas overcomeby
identifying a network topology converging into 4 key events that
were viewed as critical paths leading to steatosis (i.e., fatty acid
uptake, efflux, synthesis, and oxidation; Figure 3). The assump-
tion was that assays measuring these points of convergence
would integrate the complex interplay of upstream events and
translate them into key event measures or points of departure
that are more proximally located relative to the adverse
outcome. It is conceivable that such an approach would have
the power to capture not only single chemical exposures, but
also mixture effects, as long as the effects were upstream of the
convergent key events.
Once the convergent key events were identified and the
corresponding assays were developed, a second step was to
utilize data from those assays to predict steatotic outcomes as
well as their severity. A challenge is that the compensatory
actions of these 4 key events collectively balance liver lipid
levels. Consequently, progression toward a steatosis adverse
outcome depends on the combination and magnitude of the
change in key events and the interaction among all 4 key events
and their associated AOPs. Although in some cases, only 1 of
those 4 key events may be impacted and that 1 alone could beC 2018 The Authorssufficient to elicit the adverse outcome, in most cases it is likely
that more than 1 of the convergent key events will be affected.
This can be expected to yield consequences different from those
that might be predicted based on impacts on any one of those
key events alone. For example, an exposure that increases lipid
uptake may be sufficient to cause steatosis, whereas an
alternative exposure that also activates lipid efflux may
compensate for increased uptake and restore balance such
that no adverse outcome is observed. This is a salient example of
why the consideration of AOP networks has been viewed as
critical to the use of the AOP framework for predictive
toxicology. As such critical paths and points of convergence
are identified, AOP network analyses can inform the develop-
ment of complementary, biologically based mathematical
models that facilitate an alternatives-based (e.g., cell-based
assays) chemical evaluation workflow.Case study 2: Decreased serum thyroid hormone
AOP network for alternative assay development
An example of network-guided AOP development that has
led to de facto construction of an AOP network in the AOP-Wiki
is centered around circulating thyroid hormone concentrations.
Two major points of convergence/divergence (i.e., key events
resembling the knot of a bow-tie motif; see the Visualizing AOP
network data using layers section) in this multitaxon AOP
network are decreased serum T4 (thyroxine) and decreased
serum T3 (triidothyronine, see Figure 4A).
This thyroid hormone disruption AOP network has been
employed to support the development and application of
guideline toxicity tests and, subsequently, alternatives to those
same whole-animal test guidelines. For example, the amphibian
metamorphosis assay (Organisation for Economic Co-operation
and Development [OECD] test guideline 231; Organisation for
Economic Co-operation and Development 2009) was devel-
oped for the purpose of screening chemicals for their ability to
disrupt the thyroid hormone signaling axis in vertebrates. The
branches in the AOP network provide the scientifically plausible
and evidence-based foundation for linking the shared key event
of decreased serum T4 to impaired amphibian metamorphosis
as an indicator of thyroid axis disruption. Adverse neuro-
developmental outcomes in rodents build the case for the
relevance of the amphibian metamorphosis assay for screening
thyroid-disrupting chemicals that can be adverse to humans
(Figure 4A). Given the time- and resource-intensive nature of the
amphibian metamorphosis assay, it was desirable to replace it
with in vitro assays that could be used to screen large libraries of
chemicals for their ability to disrupt the thyroid axis. Basedon the
AOP network, assays for thyroid peroxidase activity, the sodium
iodide symporter, iodothyronine deiodinase, and iodotyrosine
deiodinase activities were developed to assess the potential
mechanisms through which chemicals could alter circulating T4
and/or tissue T3 concentrations (Figure 4A). Not all these targets
have been covered in existing high-throughput screening
programs (e.g., ToxCast, Tox21), so the AOP network helps to
inform the development of a more comprehensive screening
battery for this important mode of endocrine disruption.wileyonlinelibrary.com/ETC
FIGURE 4: Adverse outcome pathway (AOP) networks related to disruption of the thyroid axis. (A) Multitaxon thyroid hormone disruption AOP network
includingmammalian, amphibian, and teleost endpoints. Theblue regions illustrate how a taxonomic applicability layermaybeused to add relevant data
to theprimarynetwork representation. Thekeyeventshighlighted in yellow indicate2majorpointsof convergence/divergence in thenetwork, resembling
the knot of a bow-tie motif. (B) Filtered thyroid AOP network only containing key events that are relevant to fish. The dashed brown area illustrates how
additional filtering might be used to further refine the network (e.g., to only include key events that are relevant to specific life stages). The blue area
illustrates the use of a layer to indicate the presence of a feedback loop acting on an AOP in the network, and the interaction between the feedback loop
and one of the molecular initiating events in the network. Red negative sign¼ inhibition processes. Red arrow¼DIO inhibition, which decreases
conversion of T4 into T3, thereby inhibiting the feedback inhibition of T3 on TRH and TSH synthesis. IYD¼ iodotyrosine deiodinase; NIS¼ sodium-iodide
symporter; TPO¼ thyroperoxidase; DIO¼ iodothyronine deiodinase; TH¼ thyroid hormone; T4¼ thyroxine; T3¼ triiodothyronine; TRH¼ thyrotropin-
releasing hormone; TSH¼ thyroid-stimulating hormone; thyrotropin; SB¼ swim bladder.
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question was posed as to how the fish early life stage test (OECD
test guideline 210; Organisation for Economic Co-operation
and Development 2013b) might be replaced by more rapid
and cost-effective alternatives (Villeneuve et al. 2014a). Although
a modified fish embryo test (OECD test guideline 236;
Organisation for Economic Co-operation and Development
2013c) had been proposed as an alternative that could cover
muchof the toxicological spaceencompassedby the fish early life
stage test, it was recognized that certain developmental events
occurring after hatch, during the larval to juvenile transition, could
be missed. One example was swim bladder inflation, which in
common laboratory-model cyprinids such as zebrafish and
fathead minnow occurs in 2 stages: inflation of the posterior
chamber shortly after hatch, followed by inflation of the anterior
chamber several days to weeks later (Villeneuve et al. 2014a;
Nelson et al. 2016; Stinckens et al. 2016; Cavallin et al. 2017).
Although a range of biological perturbations may disrupt thiswileyonlinelibrary.com/ETCevent, decreases in circulating T4 and/or deiodination of T4 to T3
have been defined, through development of an AOP network, as
a means through which chemicals could impact swim bladder
inflation in fish, a key event that has been linked to reduced
young-of-year survival (Czesnyetal. 2005;WoolleyandQin2010).
The AOP network that focused on swim bladder inflation in fish
was subsequently integrated with the broader amphibian/
mammalian AOP network described in the previous paragraph,
resulting in a multitaxon thyroid AOP network (Figure 4).
Consequently, the same battery of in vitro assays that can
plausibly screen for thyroid-disrupting chemicals in amphibian
andmammalianmodels could also cover toxicological space that
might be missed if a fish embryo test were employed as the only
alternative to a fish early life stage test.
From a network development perspective, the thyroid AOP
network demonstrates how some of the proposed filters and
layers might be applied (Figure 4B). For example, application of
a life-stage filter would show that the AOP mediated viaC 2018 The Authors
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larval fish. If the exposure was during the embryo stage only and
the focus was inflation of the posterior chamber, then
iodothyronine deiodinase enzyme inhibition would represent
the critical path in the network. Alternatively, if the exposure
occurred or was sustained until after hatch, both thyroid
peroxidase and iodothyronine deiodinase inhibition would be
inferred to be contributing to reduced anterior swim bladder
inflation, suggesting that the outcome may be more severe
than that triggered by a chemical exhibiting only one of the
2 bioactivities. Furthermore, invoking the feedback loop layer in
the AOP network visualization could unveil additional detail
relevant to predicting the interactive effect of these 2 AOPs,
because the molecular initiating event of iodothyronine
deiodinase inhibition also impacts the negative feedback loop
mechanism itself. Adding the quantitative properties of this
feedback mechanism to the response–response relationship of
the key event relationship linking decreased T4 levels to reduced
anterior swim bladder inflation might provide for a more
accurate prediction of the joint effect of the 2 AOPs than the
basic AOP network alone would provide.Additional case studies
Two additional, fully described case studies are given in the
Supplemental Data to provide the interested reader with further
examples illustratingAOPnetworkdevelopmentandapplication in
more advanced scenarios. The first case study illustrates the
applicationofAOPnetworks to support theassessmentof complex
mixtures. A water sample extract of a metropolitan wastewater
treatment plant was tested using a number of ToxCast assays to
evaluate the ability of the sample to activate different nuclear
receptors and transcription factor promoter–regulated reporter
sequences. Assay activity was mapped to molecular initiating
events described in the AOP-Wiki, and the resulting AOP network
was filtered to focus on key events that weredirectly relevant to the
observed bioactivities. The resulting set of AOP networks was
further filtered to exclude AOPs that did not terminate at adverse
outcomes that would be considered relevant to ecological risk
assessment. Focusing on the remaining AOPs, known potential
hazards to aquatic vertebrate wildlife associated with this mixture
could be identified. The second case study provides an example of
how an AOP network approach was used to explore the
polypharmacological profile of the pharmaceutical beclometha-
sone dipropionate using the fatheadminnow. Because of its ability
to modulate the glucocorticoid receptor, beclomethasone dipro-
pionate is used to treat chronic inflammatory conditions, but the
drug also has the ability to modulate the androgen and
progesterone receptors. Data generated during drug develop-
ment were used to identify the cascades of key events likely to be
triggered, and this information was organized within an AOP
network. Chronic in vivo exposures to beclomethasone dipropi-
onate were then carried out to generate a quantitative AOP
network, which provided evidence that the polypharmacology
profile of the beclomethasone dipropionate was indeed critically
important to interpret and accurately predict the toxicological
profile of the drug (Margiotta-Casaluci et al. 2016).C 2018 The AuthorsSUMMARY AND CONCLUSIONS
Based on the results of a SETAC-sponsoredHorizon Scanning
exercise focused on advancing the AOP framework, the
development of guidance and best practices related to AOP
network derivation and application was identified as a critical
need. This not only included questions and concerns focusing
directly on AOP networks, but also on different related topics
such as mixture toxicity assessment, the implementation and
graphical representation of feedback loops within the AOP
framework, the characterization of interactions among path-
ways, the ability to include information on extrinsic modulating
factors, and so on. Although the concept of constructing
networks has always been deliberately, but possibly rather
implicitly, built into the AOP framework (Villeneuve et al. 2014b,
2014c), the number of available AOPs has only recently reached
a level sufficient to begin developing AOP networks. Recogniz-
ing different needs and strategies for developing AOP networks,
we distinguish between network-guided AOP development and
AOP network derivation based on the AOP knowledgebase. We
then propose the use of filters and layers to simplify visualization
and interpretation of AOPnetworks, and to tailor them to suit the
needs of a given research question or application. The AOP
networks can subsequently be analyzed in a variety of ways to
extract useful information, including topological analyses,
critical path identification, and characterization of interactions
among AOPs within a network. The concepts described in the
present article, and in its companion article focused on AOP
network analytics, are intended to serve as a starting point for
further development of the AOP network concept and of the
AOPknowledgebase to increase its capabilities formanagingand
analyzing AOP networks, but also to catalyze AOP network
development and application by the different stakeholder
communities. Along with other manuscripts produced as a result
of the April 2017 SETAC Pellston Workshop on Advancing the
Adverse Outcome Pathway Framework (LaLone et al. 2017a), we
hope to serve the ongoingdevelopment of theAOP framework in
general as a critical concept to support 21st century approaches
to toxicological research and regulation.
Supplemental Data—The Supplemental Data are available on
the Wiley Online Library at DOI: 10.1002/etc.4125.
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